Search by Drug Name or NDC
NDC 55494-0120-60 BONJESTA 20; 20 mg/1; mg/1 Details
BONJESTA 20; 20 mg/1; mg/1
BONJESTA is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Duchesnay USA, Inc.. The primary component is DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE.
Product Information
| NDC | 55494-0120 |
|---|---|
| Product ID | 55494-120_af3a70f8-e0ea-4863-a89b-55e3ebe481f3 |
| Associated GPIs | 50309902100430 |
| GCN Sequence Number | 076841 |
| GCN Sequence Number Description | doxylamine succinate/vit B6 TAB IR DR 20 MG-20MG ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 42645 |
| HICL Sequence Number | 001970 |
| HICL Sequence Number Description | DOXYLAMINE SUCCINATE/PYRIDOXINE HCL (VITAMIN B6) |
| Brand/Generic | Brand |
| Proprietary Name | BONJESTA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | doxylamine succinate and pyridoxine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 20; 20 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE |
| Labeler Name | Duchesnay USA, Inc. |
| Pharmaceutical Class | Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA209661 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55494-0120-60 (55494012060)
| NDC Package Code | 55494-120-60 |
|---|---|
| Billing NDC | 55494012060 |
| Package | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (55494-120-60) |
| Marketing Start Date | 2018-02-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 11.1778 |
| Pricing Unit | EA |
| Effective Date | 2023-05-17 |
| NDC Description | BONJESTA ER 20-20 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis